Concepedia

Tau pathology-mediated presynaptic dysfunction

Herman Moreno, Gerardo Morfini, Luna Buitrago, G. Ujlaki, Soonwook Choi, Eunah Yu, Jorge E. Moreira, Jesús Ávila, S.T. Brady, H. Pant,

Neuroscience · 2016 · 64 citations · 37 references

DOIFull text

Open access

Concepts

References

37

Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy

Maj-Linda B. Selenica, Milene L. Brownlow, Jeffy P. Jimenez et al. · Neurodegenerative Diseases · 2012 · 10.4K citations · Full text

, , +17

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

Alix de Calignon, Manuela Polydoro, Marc Suárez‐Calvet et al. · Neuron · 2012 · 1.4K citations · Full text

, , +14

2APB, 2-Aminoethoxydiphenyl Borate, a Membrane-Penetrable Modulator of Ins(1,4,5)P3-Induced Ca2+ Release

Takayuki Maruyama, Toshiya Kanaji, Shinji Nakade et al. · The Journal of Biochemistry · 1997 · 915 citations

, , +12

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross et al. · Chemistry & Biology · 2000 · 895 citations · Full text

, , +11

Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse.

R. Llinás, T L McGuinness, Christopher S. Leonard et al. · Proceedings of the National Academy of Sciences · 1985 · 641 citations · Full text

, , +17